Celldex Therapeutics, Inc. (CLDX) Shareholders’ equity 2016–2025
Celldex Therapeutics, Inc. (CLDX) shareholders’ equity at each fiscal year-end, per SEC filings.
$527.2MFY2025 · since FY2016: $265.4M → $527.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $527.2M | -29.4% |
| FY2024 | $747.0M | +74.1% |
| FY2023 | $429.2M | +31.6% |
| FY2022 | $326.2M | -22.2% |
| FY2021 | $419.5M | +100.4% |
| FY2020 | $209.4M | +122.7% |
| FY2019 | $94.0M | -24.2% |
| FY2018 | $124.1M | -47.5% |
| FY2017 | $236.4M | -10.9% |
| FY2016 | $265.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice